Epstein-barr Virus Infection And Gastric Carcinoma In São Paulo, Brazil by Lopes L.F. et al.
1707
Braz J Med Biol Res 37(11) 2004
EBV infection and gastric carcinoma in São Paulo StateBrazilian Journal of Medical and Biological Research (2004) 37: 1707-1712
ISSN 0100-879X
Epstein-Barr virus infection and gastric
carcinoma in São Paulo State, Brazil
1Consultoria em Patologia, Botucatu, SP, Brasil
2Departamento de Patologia, Faculdade de Medicina de Botucatu,
Universidade Estadual de São Paulo, Botucatu, SP, Brasil
3Departamento de Tocoginecologia, Faculdade de Ciências Médicas,
Universidade Estadual de Campinas, Campinas, SP, Brasil
4Hospital Israelita Albert Einstein, São Paulo, SP, Brasil
L.F. Lopes1, M.M. Bacchi1,
D. Elgui-de-Oliveira1,2,
S.G. Zanati2, M. Alvarenga3
and C.E. Bacchi1,4
Abstract
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, and most people
have serological evidence of previous viral infection at adult age. EBV
is associated with infectious mononucleosis and human cancers,
including some lymphomas and gastric carcinomas. Although EBV
was first reported in lymphoepithelioma-like gastric carcinoma, the
virus was also found in conventional adenocarcinomas. In the present
study, 53 gastric carcinomas diagnosed in São Paulo State, Brazil,
were evaluated for EBV infection by non-isotopic in situ hybridization
with a biotinylated probe (Biotin-AGACACCGTCCTCACCACCC
GGGACTTGTA) directed to the viral transcript EBER-I, which is
actively expressed in EBV latently infected cells. EBV infection was
found in 6 of 53 (11.32%) gastric carcinomas, mostly from male
patients (66.7%), with a mean age of 59 years old. Most EBV-positive
tumors were in gastric antrum. Two EBV-positive tumors (33.3%)
were conventional adenocarcinomas, whereas four (66.7%) were
classified as lymphoepithelioma-like carcinomas. EBV infection in
gastric carcinomas was reported elsewhere in frequencies that range
from 5.6% (Korea) up to 18% (Germany). In Brazil, a previous work
found EBV infection in 4 of 80 (5%) gastric carcinomas, whereas
another study found 4.7 and 11.2% of EBV-positive gastric carcino-
mas of Brazilians of Japanese origin or not, respectively. In the present
study, the frequency of EBV-positive gastric carcinomas is similar to
that reported in other series, and the clinicopathologic characteristics
of these EBV-positive tumors are in agreement with the data in the
literature.
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Introduction
Epstein-Barr virus (EBV) has been asso-
ciated with a variety of lymphoid and epithe-
lial malignancies, such as Burkitt’s lymphoma
(1,2), Hodgkin’s disease (3,4), T-cell lym-
phomas (5,6), AIDS-related lymphomas (7,
8), nasopharyngeal carcinoma (1,9,10), and
lymphoepithelioma-like carcinomas (LELC)
of several organs including salivary glands
(11), thymus (12,13), and lung (14).
Early in the 1990s, some papers reported
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the association between gastric carcinoma
and EBV infection. Burke et al. (15) first
detected EBV in a LELC of the stomach by
the polymerase chain reaction, and other
investigators also confirmed this finding (16-
21). LELC is an uncommon type of gastric
carcinoma (17,19,22) strongly associated
with EBV, with this association ranging from
77.8 to 87.5% of cases (17,19-21). Occur-
rence in elderly patients, male predominance,
gastric cardia and middle portion involve-
ment in most cases, and high survival rates
were described in association with gastric
LELC (17,19,20,22).
In 1991, Shibata et al. (17) first presented
a case of EBV-positive conventional gastric
carcinoma. Several investigators subse-
quently added new information regarding
the prevalence and clinicopathologic char-
acteristics of EBV infection in gastric carci-
nomas of different populations from North,
Central and South America, Europe and Asia;
however, there are few reports concerning
clinicopathologic data of EBV-related gas-
tric carcinomas among Brazilians, including
one study that compares characteristics of
EBV-positive gastric carcinomas from Bra-
zilians of Japanese origin or not (23).
Thus, the aim of the present study was to
provide additional information about the
prevalence and characteristics of EBV in-
fection in gastric carcinomas diagnosed in
São Paulo State, Brazil, and compare the
results with other series of EBV-positive
gastric cancer elsewhere.
Material and Methods
Case selection
Fifty-three gastrectomy specimens with
gastric carcinomas diagnosed in the Depart-
ment of Pathology, State University of São
Paulo (Botucatu, SP, Brazil), were included
in this study. Representative formalin-fixed
paraffin-embedded blocks from the tumor,
surrounding non-neoplastic gastric mucosa,
and regional lymph nodes with metastases
were selected. Gastric carcinomas were clas-
sified according to the Lauren’s classifica-
tion. The undifferentiated and lymphoepi-
thelioma-like types of carcinoma were also
considered for classification, and the criteria
for diagnosis of LELC were applied as de-
scribed by Watanabe et al. (22). Clinico-
pathologic data were obtained from patholo-
gy reports, including patient age and sex as
well as the anatomical site of the tumor
(cardia, middle portion or antrum) and the
histologic type of carcinoma.
All cases were confirmed as carcinomas
with the demonstration of keratin reactivity
by immunohistochemistry. Of the 53 pa-
tients studied, 35 were males and 17 were
females. The gender of one patient was not
available. Mean age was 58.8 years, ranging
from 30 to 80 years.
In situ hybridization
EBV infection was assessed by RNA in
situ hybridization with a 30-bp biotinylated
probe (Biotin-AGACACCGTCCTCACCAC
CCGGGACTTGTA) for RNA EBER-I, an
EBV transcript actively expressed in latently
infected cells. Briefly, tissue sections were
placed on poly-D-lysine-treated glass slides
and incubated at 70ºC for one day. After the
slides were routinely deparaffinized, endog-
enous peroxidase was blocked with 3% H2O2
solution. Enzymatic digestion was performed
with proteinase K (0.02 µg/µl final concen-
tration) and the tissues were then dehydrated
in ethanol and dried at room temperature.
The slides were incubated in prehybridi-
zation solution (20 mM sodium phosphate/
Denhardt’s solution 1X/0.1% dextran sul-
fate) for 60 min at 37ºC. After the addition of
the EBER-I probe (0.25 ng/ml final concen-
tration), tissues were incubated overnight at
37ºC in a humid chamber. The signal was
amplified with the ABC Elite kit (Vector
Corp., Burlingame, CA, USA), and the reac-
tion was developed with 3,3'-diaminobenzi-
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dine (Sigma, St. Louis, MO, USA) solution.
The slides were counterstained with methyl
green and mounted with Permount® resin
(Fischer Chemicals Inc., Fair Law, NJ, USA).
A case of nasopharynx LELC previously
known to be EBV positive was used as posi-
tive control. The cells presenting a positive
signal for EBV EBER-I RNA had dark brown
to black nuclear staining.
Results
EBER-I was positive in 6 of the 53 cases
(11.3%). Five of the 6 positive cases (83.3%)
were male patients, with a mean age of 59
years, ranging from 52 to 67 years. The only
female patient with an EBER-I-positive gas-
tric carcinoma was 65 years old.
Pathologic and in situ hybridization findings
According to the anatomical site of the
gastric carcinoma, 22 (41.5%) carcinomas
were present in the antrum, 6 (11.3%) in the
middle portion of the stomach, and 5 (9.4%)
in the cardia. Unfortunately, information re-
garding the anatomical site was unavailable
for 3 EBV-positive cases. Two (33.3%) of
the 6 EBV-positive cases were localized in
the antrum and one (16.6%) in the middle
portion of the stomach.
The distribution of the histological types
of carcinomas (including EBV-positive
cases) is shown in Table 1. Among the 6
EBV-positive carcinomas, 2 (33.3%) were
conventional carcinomas of tubular (Figure
1A) and undifferentiated types (Figure 1E),
and 4 (66.7%) were LELC (Figure 1C). The
EBER-I signal was uniformly distributed in
the nuclei of carcinoma cells in all 6 positive
cases (Figure 1B,D,F). The surrounding lym-
phocytes and non-neoplastic gastric mucosa
with chronic gastritis or intestinal metapla-
sia were EBV negative. It is worth noting
that EBV sequences were also detected in a
case with metastatic carcinoma in regional
lymph nodes. This finding indicates that the
Table 1. Distribution of gastric carcinomas in Brazilian patients by histologic type.
Histologic types Total EBER-I-positive cases
Intestinal (including tubular adenocarcinoma) 27 (51.0%) 1 (37%)
Diffuse 18 (34%) - (0%)
Undifferentiated 1 (1.8%) 1 (100%)
LELC 7 (13.2%) 4 (57.1%)
Total 53 (100%) 6 (11.3%)
LELC, lymphoepithelioma-like carcinoma.
Figure 1. Photomicrographs of the Epstein-Barr virus-positive carcinomas. A, Tubular
adenocarcinoma (hematoxylin and eosin, 400X). B, Tubular adenocarcinoma showing
nuclear EBER-I signals (EBER-I, 400X). C, Lymphoepithelioma-like carcinoma (hematoxylin
and eosin, 400X). D, Lymphoepithelioma-like carcinoma showing nuclear EBER-I signals
(EBER-I, 400X). E, Undifferentiated carcinoma (hematoxylin and eosin, 400X). F, Undiffer-
entiated carcinoma showing nuclear EBER-I signals (EBER-I, 400X).
metastatic gastric carcinoma recapitulates
the EBV infection in the neoplastic cells
from the primary tumor.
50 µm
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Discussion
The Brazilian National Cancer Institute
(Instituto Nacional do Câncer, INCA) re-
ports 20,000 new cases of gastric cancer
yearly, and it is believed that about 11,000
patients die because of the disease (24).
Diet, smoking, alcohol intake, previous gas-
tric surgery, and some gastric diseases, such
as pernicious anemia, gastritis and Helico-
bacter pylori infection, are considered to be
risk factors for the development of cancer.
The association between EBV and gastric
cancer was first detected by Burke et al. (15),
and many reports showing this strong asso-
ciation have been published since then.
The frequency of EBV-positive gastric
carcinomas can reach up to 18% (19,21,
23,25-39), as reported in Germany (39). In
Eastern countries, e.g., Japan, China and
Taiwan, EBV-positive gastric cancer com-
prises 5.6 to 13.5% of cases (19,21,29-36).
In Russia, Galetsky et al. (37) reported a
frequency of 8.7%. In the US (including
Hawaii) and Mexico, 8.15 to 16% of gastric
carcinomas were EBV positive (25-28).
In Brazil, Hayashi et al. (40) found EBV
infection in 4 of 80 (5.0%) gastric carcino-
mas of Brazilian patients, and in 29 of 510
(5.7%) gastric carcinomas of Japanese pa-
tients. Few EBV-positive gastric carcinomas
(9/33 cases or 27.3%) were classified as
LELC. This might explain the lower rate of
EBV infection observed in these tumors. In a
study published in 2001, Koriyama et al.
(23) reported 4.7 and 11.2% of EBV-posi-
tive gastric carcinomas in Brazilians of Japa-
nese origin (N = 148) or not (N = 150),
respectively. Interestingly, all these EBV-
positive gastric carcinomas were classified
as conventional carcinomas. In the present
study, the frequency of EBV infection in
gastric carcinomas was 11.32%, and most of
them were classified as LELC (4/6, 66.7%).
Occurrence in elderly persons and male
predominance are common in EBV-associ-
ated gastric carcinomas (23,25,27,29,31-37),
and these findings were also observed in the
present study. However, the site where EBV-
positive gastric carcinoma more often arises
is a controversial issue in the literature. Some
studies have reported that the cardia and
middle portion of the stomach are more fre-
quently involved (29-31,33,37), whereas oth-
ers have found that the antrum was the most
typical site (23,28,32). In the present study,
the antrum was the most common anatomic
site involved by EBV-positive gastric carci-
nomas. Moderately to poorly differentiated
conventional carcinomas and diffuse histol-
ogy have also been associated with EBV-
positive gastric cancers (23,27-29,31-33,36,
37), but the prognosis does not seem to be
influenced by these characteristics (27,36).
Unfortunately, no additional information is
available regarding the follow-up of the pa-
tients with EBV-positive gastric carcinomas
included in the present study.
EBV infection in gastric carcinomas in
São Paulo State, Brazil, as well as their
clinicopathologic characteristics, are similar
to those reported for other countries. Addi-
tional studies are needed in order to obtain
information regarding the biological behav-
ior of EBV-positive gastric carcinomas in
Brazilian patients.
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